Hefei Lifeon Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Hefei Lifeon Pharmaceutical has a total shareholder equity of CN¥1.9B and total debt of CN¥31.0M, which brings its debt-to-equity ratio to 1.6%. Its total assets and total liabilities are CN¥2.5B and CN¥585.5M respectively. Hefei Lifeon Pharmaceutical's EBIT is CN¥152.9M making its interest coverage ratio -4.6. It has cash and short-term investments of CN¥510.2M.
Key information
1.6%
Debt to equity ratio
CN¥31.00m
Debt
Interest coverage ratio | -4.6x |
Cash | CN¥510.24m |
Equity | CN¥1.91b |
Total liabilities | CN¥585.55m |
Total assets | CN¥2.49b |
Recent financial health updates
No updates
Recent updates
Hefei Lifeon Pharmaceutical (SZSE:003020) Has Announced A Dividend Of CN¥0.50
May 23Investors Still Aren't Entirely Convinced By Hefei Lifeon Pharmaceutical Co., Ltd.'s (SZSE:003020) Earnings Despite 25% Price Jump
May 22Hefei Lifeon Pharmaceutical's (SZSE:003020) Profits May Not Reveal Underlying Issues
Apr 29Financial Position Analysis
Short Term Liabilities: 003020's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥520.4M).
Long Term Liabilities: 003020's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥65.2M).
Debt to Equity History and Analysis
Debt Level: 003020 has more cash than its total debt.
Reducing Debt: 003020's debt to equity ratio has reduced from 6.1% to 1.6% over the past 5 years.
Debt Coverage: 003020's debt is well covered by operating cash flow (637.3%).
Interest Coverage: 003020 earns more interest than it pays, so coverage of interest payments is not a concern.